Kevin Ens is MTI's Chief Operating Officer and has over 30 years of strategic and operational management experience in biotechnology and medical devices.
Ian Fodie is MTI’s Chief Financial Officer. He brings over 30 years of experience in high growth industries, including biotechnology, life sciences, entertainment, and exploration and development, with international activities focused on intangible and real properties.
David Schodin is Head of Strategy for MTI. He has worked extensively in corporate development, partnership and alliance formation and execution, intellectual property strategy and licensing, and biotechnology evaluation in the diagnostics and pharmaceutical industries. David earned a JD (summa cum laude) from Chicago-Kent School of law and holds a PhD in biochemistry from the University of Illinois at Urbana-Champaign.
Dr. Haili Wang is a colorectal surgeon and Associate Professor at the University of Alberta. She also holds an MSc. in Clinical Epidemiology from the University of Alberta, where her expertise in colorectal cancer led her to the discovery of novel urine diagnostics for improved colorectal cancer screening.
Dr. Lu Deng is a healthcare and life sciences innovator and inventor who thrives in bringing research innovation to clinical application. Lu has over ten years of experience in the field of metabolomics and mass spectrometry.
Jean Forsythe has extensive experience in project management and business development in industry and academia. Before joining MTI, Jean was a Campaign Coordinator for development at Stanford University. She has a BA from the University of British Columbia.
Dr. Azeret Zuniga, has over 6 years' GMP experience in the pharmaceutical industry, with extensive experience with USFDA and Health Canada compliance. She holds both a PhD in Analytical Chemistry from the University of Alberta and is an American Society of Quality (ASQ) Certified Quality Auditor (CQA).
Rebecca Lin has more than 10 years' experience in the field of analytical chemistry, specializing in Metabolomics and Mass Spectrometry.
Ashley Xia has more than 9 years' experience in analytical chemistry, specializing in mass spectrometry, metabolomics, and data analysis. She has a MSc. from the University of Alberta, and a Bachelor of Pharmacy Science from Shenyang Pharmaceutical University.